AVIR Latest Quarter’s Earnings
Announce Date8/12/2026
EPS Actual (USD)-0.41
Revenue Actual (USD)--
Atea Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed Atea Pharmaceuticals Inc earnings data including the latest Atea Pharmaceuticals Inc earnings report, the upcoming Atea Pharmaceuticals Inc earnings date, historical data and Atea Pharmaceuticals Inc earnings call news.
AVIR Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
AVIR FY2025 Earnings
EPS (YoY)-1.942.76%
Revenue (YoY)----
Atea Pharmaceuticals Inc (AVIR) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/12/2026 | 06/2026 | -0.41/-0.56 | --/0.00 | 26.54% | -- |
| 5/12/2026 | 03/2026 | -0.57/-0.59 | --/0.00 | 2.75% | -- |
| 3/5/2026 | 12/2025 | -0.57/-0.53 | --/0.00 | -8.38% | -- |
| 11/12/2025 | 09/2025 | -0.53/-0.44 | --/0.00 | -20.89% | -- |
| 8/7/2025 | 06/2025 | -0.44/-0.41 | --/0.00 | -6.92% | -- |
| 5/12/2025 | 03/2025 | -0.40/-0.41 | --/0.00 | 1.84% | -- |
| 3/6/2025 | 12/2024 | -0.40/-0.37 | --/0.00 | -7.33% | -- |
| 11/7/2024 | 09/2024 | -0.37/-0.49 | --/0.00 | 25.46% | -- |
Atea Pharmaceuticals Inc Latest Earnings Call Transcripts
Atea Pharmaceuticals (AVIR) Q2 2026 Earnings Call: C-BEYOND Meets Phase 3 Endpoint
Atea Pharmaceuticals’ Q2 2026 earnings call covered positive Phase 3 C-BEYOND HCV data, $219.5 million in cash and key 2027 regulatory milestones.